NEOPRISM-CRC News

Latest Articles

• Zero Relapse Rate Reported in UCL Trial Using Pre-Operative Immunotherapy for High-Risk Bowel Cancer

  Published: Apr 21, 2026

  Section: Medical News

  The NEOPRISM-CRC clinical trial, led by University College London (UCL) and UCLH, has demonstrated a remarkable 100% cancer-free rate after three years for patients with specific h...